Family · Pharmaceutical analytical standards
Midazolam
A short-acting benzodiazepine synthesised in the United States in 1975 and in clinical use since 1982: it is used for sedation before medical procedures, in anaesthesia and against prolonged seizures. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards, nitrosamines and other impurities.
Did you know?In acidic solution up to 40% of the molecule exists in a water-soluble form with one ring opened: once in the body, the ring closes again, restoring the active, lipophilic form.
No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
